Cardiac Rehabilitation for Patients With Stable Ischemic Heart Disease Without Revascularization - Rationale and Design of a Single-Arm Pilot Study
- PMID: 36909138
- PMCID: PMC9992498
- DOI: 10.1253/circrep.CR-22-0131
Cardiac Rehabilitation for Patients With Stable Ischemic Heart Disease Without Revascularization - Rationale and Design of a Single-Arm Pilot Study
Abstract
Background: Clinical practice guidelines strongly recommend optimal medical therapy (OMT), including lifestyle modification, pharmacotherapy, and exercise-based cardiac rehabilitation (CR), in patients with stable ischemic heart disease (SIHD). However, the efficacy and safety of CR in patients with SIHD without revascularization remain unclear. Methods and Results: The Prospective Registry of STable Angina RehabiliTation (Pre-START) study is a multicenter, prospective, single-arm, open-label pilot study to evaluate the efficacy and safety of CR on health-related quality of life (HRQL), exercise capacity, and clinical outcomes in Japanese patients with SIHD without revascularization. In this study, all patients will undergo guideline-based OMT and are encouraged to have 36 outpatient CR sessions within 5 months after enrollment. The primary endpoint is the change in the Seattle Angina Questionnaire-7 summary score between baseline and the 6-month visit; an improvement of ≥5 points will be defined as a clinically important change. Secondary endpoints include changes in other HRQL scores and exercise capacity between baseline and the 6-month visit, as well as clinical outcomes between enrollment and the 6-month visit. Conclusions: The Pre-START study will provide valuable evidence to elucidate the efficacy and safety of CR in patients with SIHD and indispensable information for a subsequent randomized controlled trial. The study was registered with the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (ID: UMIN000045415) on April 1, 2022.
Keywords: Cardiac rehabilitation; Coronary artery disease; Quality of life; Stable angina.
Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY.
Conflict of interest statement
All authors have reported that they have no relationships relevant to the contents of this article to disclose. S.K. is a member of Circulation Reports’ Editorial Team.
Figures

References
-
- Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al.. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503–1516. - PubMed
-
- Bangalore S, Maron DJ, Stone GW, Hochman JS.. Routine revascularization versus initial medical therapy for stable ischemic heart disease. Circulation 2020; 142: 841–857. - PubMed
-
- Soares A, Boden WE, Hueb W, Brooks MM, Vlachos HEA, O’Fee K, et al.. Death and myocardial infarction following initial revascularization versus optimal medical therapy in chronic coronary syndromes with myocardial ischemia: A systematic review and meta-analysis of contemporary randomized controlled trials. J Am Heart Assoc 2021; 10: e019114. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous